F035-0269 Screening compound: 1-[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide

F035-0269 Screening compound: 1-[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide
F035-0269 Screening compound: 1-[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F035-0269
1-[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F035-0269

Molecular Formula

C24H25F3N4O4 (C24 H25 F3 N4 O4)

Compound Name

1-[3-(4-ethoxy-3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-N-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide

IUPAC name

1-[3-(4-ethoxy-3-methoxyphenyl)-124-oxadiazol-5-yl]-N-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide

SMILES

CCOc(ccc(-c1noc(N(CC2)CCC2C(Nc2cccc(C(F)(F)F)c2)=O)n1)c1)c1OC

InChI

InChI=1S/C24H25F3N4O4/c1-3-34-19-8-7-16(13-20(19)33-2)21-29-23(35-30-21)31-11-9-15(10-12-31)22(32)28-18-6-4-5-17(14-18)24(25,26)27/h4-8,13-15H,3,9-12H2,1-2H3,(H,28,32)

InChI Key

LDSRGXBQRVOWOF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27096172

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.817

Distribution Coefficient, logD

4.815

Water Solubility, LogSw

-4.59

Polar Surface Area

73.371

Acid Dissociation Constant (pKa)

9.67

Base Dissociation Constant (pKb)

1.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

F035-0269 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with F035-0269 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F035-0269?
Check Price and Availability of F035-0269, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F035-0269 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F035-0269
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F035-0269
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F035-0269 available by request